Colorectal cancer (CRC): EU approved Opdivo+Yervoy dual immunotherapy Colorectal cancer (CRC): EU approved Opdivo+Yervoy dual immunotherapy. Colorectal cancer...
Immunotherapy
The Lancet: Develop a new type of CAR-T cell therapy for multiple myeloma! Lancet: Develop a new type...
EU approved Libtayo immunotherapy for lung cancer and basal cell carcinoma! EU approved Libtayo immunotherapy for lung cancer...
Where do the NK cells used for immunotherapy come from? Where do the NK cells used for immunotherapy come from? ...
Immunotherapy may make lung cancer to become a "chronic disease" Immunotherapy may make lung cancer to become a "chronic...
Success and failure of CAR-T and double antibodies based on BCMA target Success and failure of CAR-T and...
Bioreactor system for clinical scale expansion of T cells Bioreactor system for clinical scale expansion of T cells....
Does NSCLC immunotherapy require concurrent radiotherapy and chemotherapy? Does NSCLC immunotherapy require concurrent radiotherapy and chemotherapy? Immunotherapy + radiotherapy...
The new type of immunotherapy may eliminate all advanced tumor cells The new type of immunotherapy may eliminate...
Cytokine release syndrome and related neurotoxicity of CAR-T cell therapy Cytokine release syndrome and related neurotoxicity of CAR-T...
Merck's Keytruda+platinum chemotherapy phase 3 clinical success Merck's Keytruda+platinum chemotherapy phase 3 clinical success. First-line immunotherapy for cervical cancer! Merck's...
Renal cell carcinoma (RCC): Lenvima + Keytruda with strong efficacy! Renal cell carcinoma (RCC): Lenvima + Keytruda with strong...
CAR-T cell therapy for pediatric acute lymphoblastic leukemia-past, present and future CAR-T cell therapy for pediatric acute lymphoblastic...
What is the immunogenicity of CAR-T cells in cancer treatment? What is the immunogenicity of CAR-T cells in...
Clinical application of interleukin in tumor immunotherapy Clinical application of interleukin in tumor immunotherapy. Interleukins and related cytokines...
IL-30: A cytokine that promotes cancer development IL-30: A cytokine that promotes cancer development. IL-30 was discovered in 2002,...
Tisagenlecleucel to treat adult relapsed or refractory diffuse large B-cell lymphoma Tisagenlecleucel to treat relapsed or refractory diffuse...
First-line treatment of advanced nasopharyngeal cancer by immunotherapy First-line treatment of advanced nasopharyngeal cancer by immunotherapy. A study evaluating the...
CAR-T is still the mainstream in Global cancer cell immunotherapy projects. CAR-T is still the mainstream in Global...
How to use non-viral methods to produce CAR T cells? How to use non-viral methods to produce CAR...
CAR-T-mediated immunotherapy for glioblastoma multiforme CAR-T-mediated immunotherapy for glioblastoma multiforme. The broad categories of immunotherapy include cancer vaccines,...
What is the difference among three atypical T cells: NKT MAIT and γδT? What is the difference among three...
Summary of Mechanism and Strategy of Gene Therapy in Disease Treatment Summary of Mechanism and Strategy of Gene Therapy...
The emerging vision of immune cell therapy The emerging vision of immune cell therapy. Fundamental advances in immunology,...
How to choose the subtype of antibody for tumor immunotherapy? How to choose the subtype of antibody for tumor...
Nature: Demystifying the "dormancy" mechanism of tumor cells and effectively preventing metastatic cancer "Dormancy" mechanism of tumor cells and preventing...
Nature: Global cancer cell therapy research and development pipeline summary, rapid growth, China and the United States lead Nature:...
Enhance the anti-tumor function of CAR-T cells by advanced media design Enhance the anti-tumor function of CAR-T cells by advanced...
How T cell gene therapy treats immunodeficiency? How T cell gene therapy treats immunodeficiency? In the past few decades, therapeutic...
Janssen BCMA double antibody + CAR-T cell have made progress! Janssen BCMA double antibody + CAR-T cell have...